drugset / Trial / NCT03860870

Response to Clenbuterol in Humans

NCT03860870

Completed 16 enrolled University of Copenhagen
RandomizedCrossoverQuadruple-blindBasic science

Summary

Due to the long half-life (\~36 hr) of clenbuterol, detection methods such as dried blood spots (DBS) are a potentially suitable method to easily and non-invasively detect doping misuse of this compound for several days after ingestion. If, and how long, the compound can be detected by DBS has not yet been investigated but is of interest due to its potential in doping-control. The aim is to evaluate whether abuse of clenbuterol can be detected at relevant concentration levels in samples obtained using DBS and to assess the physiological response to clenbuterol in skeletal muscle..

Timeline

Start
2019-03-11
Primary completion
2022-12-21
Completion
2022-12-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Clenbuterol Small molecule 80 ug Oral

Indications

No indication recorded.